TapewireFind a company

person · Reporting owner

Lemaitre Dan

Disclosed activity across 2 companies

Tapewire entity
68899
SEC CIK
0001478479

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ENDOLOGIX INC /DE/ELGX · Entity 146591DirectorSeptember 04, 2020September 17, 2020
GLOBUS MEDICAL INCGMED · Entity 3496DirectorJanuary 21, 2026January 23, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ENDOLOGIX INC /DE/

Report date September 04, 2020 · Filed September 17, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Ending reported balance After 2020-09-04 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2020-09-04 · Sale · Disposed 2,582 · Balance 49,262

Row 2 · 2020-09-04 · Sale · Disposed 33,709 · Balance 15,553

Row 3 · 2020-09-04 · Sale · Disposed 15,553 · Balance 0

GLOBUS MEDICAL INC

Report date January 21, 2026 · Filed January 23, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21Direct15,000 Reported balance After 2026-01-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-01-21 · Grant · Acquired 15,000 · Balance 15,000

F1: These options were granted on January 21, 2026, and will vest on January 1, 2027.

Filing footnotes · ownership attribution and instrument terms

F1: These options were granted on January 21, 2026, and will vest on January 1, 2027.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 21, 2026 Filed Jan 23, 2026 16:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 15,000 $0.00 Strike: $94.15 $0.00
Disclosure

SEC source: 0001193125-26-021222 · ownership.xml · derivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2036-01-21

F1 · derivative.exercise_date: These options were granted on January 21, 2026, and will vest on January 1, 2027.

Read SEC document
January 23, 2025 Filed Mar 28, 2025 19:09 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 15,000 $0.00 Strike: $92.42 $0.00
Disclosure

SEC source: 0000950170-25-047045 · ownership.xml · derivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2035-01-23

F1 · derivative.exercise_date: These options were granted on January 23, 2025, and will vest on January 1, 2026.

Read SEC document
November 22, 2024 Filed Nov 25, 2024 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 1,097 $0.00 Strike: $65.05 $0.00
Disclosure

SEC source: 0000950170-24-130597 · ownership.xml · derivative · entry 6

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 625

Underlying: Class A Common Stock · 1,097 shares

Expires 2031-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on January 14, 2021 and are fully vested.

Read SEC document
November 22, 2024 Filed Nov 25, 2024 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 1,097 $85.02 $93,263.21
Disclosure

SEC source: 0000950170-24-130597 · ownership.xml · nonDerivative · entry 4

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
November 22, 2024 Filed Nov 25, 2024 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 1,097 $65.05 $71,359.85
Disclosure

SEC source: 0000950170-24-130597 · ownership.xml · nonDerivative · entry 3

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,097

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 13,278 $0.00 Strike: $65.05 $0.00
Disclosure

SEC source: 0000950170-24-130597 · ownership.xml · derivative · entry 5

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,722

Underlying: Class A Common Stock · 13,278 shares

Expires 2031-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on January 14, 2021 and are fully vested.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 13,278 $85.00 $1,128,630.00
Disclosure

SEC source: 0000950170-24-130597 · ownership.xml · nonDerivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
November 21, 2024 Filed Nov 25, 2024 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 13,278 $65.05 $863,733.90
Disclosure

SEC source: 0000950170-24-130597 · ownership.xml · nonDerivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,278

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2024 Filed May 14, 2024 17:16 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 17,500 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0000950170-24-059787 · ownership.xml · derivative · entry 7

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 17,500 shares

Expires 2030-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on January 22, 2020 and are fully vested.

Read SEC document
May 10, 2024 Filed May 14, 2024 17:16 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 17,500 $0.00 Strike: $43.58 $0.00
Disclosure

SEC source: 0000950170-24-059787 · ownership.xml · derivative · entry 6

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 17,500 shares

Expires 2029-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on January 22, 2019 and are fully vested.

Read SEC document
May 10, 2024 Filed May 14, 2024 17:16 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 17,500 $0.00 Strike: $43.77 $0.00
Disclosure

SEC source: 0000950170-24-059787 · ownership.xml · derivative · entry 5

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 17,500 shares

Expires 2028-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on January 22, 2018 and are fully vested.

Read SEC document
May 10, 2024 Filed May 14, 2024 17:16 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 63,300 $64.61 $4,090,021.89
Disclosure

SEC source: 0000950170-24-059787 · ownership.xml · nonDerivative · entry 4

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.80 to $64.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
May 10, 2024 Filed May 14, 2024 17:16 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 17,500 $53.27 $932,225.00
Disclosure

SEC source: 0000950170-24-059787 · ownership.xml · nonDerivative · entry 3

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2024 Filed May 14, 2024 17:16 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 17,500 $43.58 $762,650.00
Disclosure

SEC source: 0000950170-24-059787 · ownership.xml · nonDerivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 10, 2024 Filed May 14, 2024 17:16 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 17,500 $43.77 $765,975.00
Disclosure

SEC source: 0000950170-24-059787 · ownership.xml · nonDerivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 15,000 $0.00 Strike: $53.75 $0.00
Disclosure

SEC source: 0000950170-24-008931 · ownership.xml · derivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2034-01-26

F1 · derivative.exercise_date: These options were granted on January 26, 2024, and will vest on January 1, 2025.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 17,500 $0.00 Strike: $26.27 $0.00
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · derivative · entry 9

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 17,500 shares

Expires 2027-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on January 30, 2017 and are fully vested.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 14,000 $0.00 Strike: $25.52 $0.00
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · derivative · entry 8

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 14,000 shares

Expires 2026-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on January 25, 2016 and are fully vested.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 10,500 $0.00 Strike: $24.10 $0.00
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · derivative · entry 7

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 10,500 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on January 20, 2015 and are fully vested.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 1,450 $0.00 Strike: $23.95 $0.00
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · derivative · entry 6

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 1,450 shares

Expires 2024-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on January 23, 2014 and are fully vested.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 43,450 $56.98 $2,475,976.53
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 5

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,800

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.77 to $57.215, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 17,500 $26.27 $459,725.00
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 4

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 14,000 $25.52 $357,280.00
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 3

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 10,500 $24.10 $253,050.00
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 1,450 $23.95 $34,727.50
Disclosure

SEC source: 0001209191-23-030202 · doc4.xml · nonDerivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2023 Filed Feb 13, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 5,550 $0.00 Strike: $23.95 $0.00
Disclosure

SEC source: 0001209191-23-008737 · doc4.xml · derivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,450

Underlying: Class A Common Stock · 5,550 shares

Expires 2024-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on January 23, 2014 and are fully vested.

Read SEC document
February 09, 2023 Filed Feb 13, 2023 16:31 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 5,550 $23.95 $132,922.50
Disclosure

SEC source: 0001209191-23-008737 · doc4.xml · nonDerivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 16:34 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 5,250 $0.00 Strike: $12.59 $0.00
Disclosure

SEC source: 0001209191-23-005484 · doc4.xml · derivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 5,250 shares

Expires 2023-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on January 30, 2013 and are fully vested.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 16:34 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 5,250 $12.59 $66,097.50
Disclosure

SEC source: 0001209191-23-005484 · doc4.xml · nonDerivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 26, 2023 Filed Feb 27, 2023 16:57 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 15,000 $0.00 Strike: $75.18 $0.00
Disclosure

SEC source: 0001209191-23-013232 · doc4.xml · derivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2033-01-26

F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
August 25, 2022 Filed Jan 18, 2023 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 OtherStock Option (Right to Buy Class A Common Stock) · Derivative 7,500 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 8

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Class A Common Stock · 7,500 shares

Expires 2030-01-22

F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.

F9 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
August 25, 2022 Filed Jan 18, 2023 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 OtherStock Option (Right to Buy Class A Common Stock) · Derivative 7,500 $0.00 Strike: $43.58 $0.00
Disclosure

SEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 7

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Class A Common Stock · 7,500 shares

Expires 2029-01-22

F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.

F8 · derivative.exercise_date: These options were granted on January 22, 2019 and are fully vested.

Read SEC document
August 25, 2022 Filed Jan 18, 2023 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 OtherStock Option (Right to Buy Class A Common Stock) · Derivative 7,500 $0.00 Strike: $43.77 $0.00
Disclosure

SEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 6

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Class A Common Stock · 7,500 shares

Expires 2028-01-22

F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.

F7 · derivative.exercise_date: These options were granted on January 22, 2018 and are fully vested.

Read SEC document
August 25, 2022 Filed Jan 18, 2023 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 OtherStock Option (Right to Buy Class A Common Stock) · Derivative 7,500 $0.00 Strike: $26.27 $0.00
Disclosure

SEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 5

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Class A Common Stock · 7,500 shares

Expires 2027-01-30

F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.

F6 · derivative.exercise_date: These options were granted on January 30, 2017 and are fully vested.

Read SEC document
August 25, 2022 Filed Jan 18, 2023 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 OtherStock Option (Right to Buy Class A Common Stock) · Derivative 6,000 $0.00 Strike: $25.52 $0.00
Disclosure

SEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 4

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Class A Common Stock · 6,000 shares

Expires 2026-01-25

F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.

F5 · derivative.exercise_date: These options were granted on January 25, 2016 and are fully vested.

Read SEC document
August 25, 2022 Filed Jan 18, 2023 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 OtherStock Option (Right to Buy Class A Common Stock) · Derivative 4,500 $0.00 Strike: $24.10 $0.00
Disclosure

SEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 3

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

Underlying: Class A Common Stock · 4,500 shares

Expires 2025-01-20

F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.

F4 · derivative.exercise_date: These options were granted on January 20, 2015 and are fully vested.

Read SEC document
August 25, 2022 Filed Jan 18, 2023 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 OtherStock Option (Right to Buy Class A Common Stock) · Derivative 3,000 $0.00 Strike: $23.95 $0.00
Disclosure

SEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Class A Common Stock · 3,000 shares

Expires 2024-01-23

F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.

F3 · derivative.exercise_date: These options were granted on January 23, 2014 and are fully vested.

Read SEC document
August 25, 2022 Filed Jan 18, 2023 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 OtherStock Option (Right to Buy Class A Common Stock) · Derivative 2,250 $0.00 Strike: $12.59 $0.00
Disclosure

SEC source: 0001209191-23-003772 · doc4.xml · derivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,250

Underlying: Class A Common Stock · 2,250 shares

Expires 2023-01-30

F1 · kind: The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.

F2 · derivative.exercise_date: These options were granted on January 30, 2013 and are fully vested.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 16:55 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 15,000 $0.00 Strike: $63.68 $0.00
Disclosure

SEC source: 0001209191-22-005607 · doc4.xml · derivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2032-01-27

F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 16:39 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 15,384 $0.00 Strike: $11.28 $0.00
Disclosure

SEC source: 0001209191-21-019789 · doc4.xml · derivative · entry 3

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 15,384 shares

Expires 2021-04-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Initially the stock option provided a right to buy the Company's Class C Common Stock. Upon the closing of the Company's initial public offering, all shares of the Company's Class C Common Stock automatically converted into shares of the Company's Class A Common Stock on a one-for-one basis. As a result, this stock option automatically converted into a right to buy the Company's Class A Common Stock.

F3 · derivative.exercise_date: These options were granted on April 20, 2011 and are fully vested.

F2 · derivative.underlying: Initially the stock option provided a right to buy the Company's Class C Common Stock. Upon the closing of the Company's initial public offering, all shares of the Company's Class C Common Stock automatically converted into shares of the Company's Class A Common Stock on a one-for-one basis. As a result, this stock option automatically converted into a right to buy the Company's Class A Common Stock.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 16:39 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 15,384 $62.47 $961,038.48
Disclosure

SEC source: 0001209191-21-019789 · doc4.xml · nonDerivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.12 to $62.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 16:39 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 15,384 $11.28 $173,531.52
Disclosure

SEC source: 0001209191-21-019789 · doc4.xml · nonDerivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,384

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 14, 2021 Filed Jan 19, 2021 17:01 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 15,000 $0.00 Strike: $65.05 $0.00
Disclosure

SEC source: 0001209191-21-004051 · doc4.xml · derivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Class A Common Stock · 15,000 shares

Expires 2031-01-14

F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
September 04, 2020 Filed Sep 17, 2020 16:35 UTC ENDOLOGIX INC /DE/ ELGX · Entity 146591 SaleCommon Stock 15,553 $0.05 $810.31
Disclosure

SEC source: 0001013606-20-000175 · wf-form4_160037493728657.xml · nonDerivative · entry 3

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 04, 2020 Filed Sep 17, 2020 16:35 UTC ENDOLOGIX INC /DE/ ELGX · Entity 146591 SaleCommon Stock 33,709 $0.05 $1,688.82
Disclosure

SEC source: 0001013606-20-000175 · wf-form4_160037493728657.xml · nonDerivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,553

Read SEC document
September 04, 2020 Filed Sep 17, 2020 16:35 UTC ENDOLOGIX INC /DE/ ELGX · Entity 146591 SaleCommon Stock 2,582 $0.05 $129.10
Disclosure

SEC source: 0001013606-20-000175 · wf-form4_160037493728657.xml · nonDerivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,262

Read SEC document
August 14, 2020 Filed Aug 19, 2020 19:58 UTC ENDOLOGIX INC /DE/ ELGX · Entity 146591 SaleCommon Stock 1,127 $0.08 $91.96
Disclosure

SEC source: 0001013606-20-000173 · wf-form4_159788148210714.xml · nonDerivative · entry 2

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,844

Read SEC document
August 13, 2020 Filed Aug 19, 2020 19:58 UTC ENDOLOGIX INC /DE/ ELGX · Entity 146591 SaleCommon Stock 1,126 $0.09 $98.41
Disclosure

SEC source: 0001013606-20-000173 · wf-form4_159788148210714.xml · nonDerivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,971

Read SEC document
January 22, 2020 Filed Jan 24, 2020 16:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 25,000 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-20-004864 · doc4.xml · derivative · entry 1

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Class A Common Stock · 25,000 shares

Expires 2030-01-22

F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
September 30, 2019 Filed Oct 1, 2019 16:29 UTC ENDOLOGIX INC /DE/ ELGX · Entity 146591 GrantOption to Purchase · Derivative 2,834 Not disclosed Strike: $4.71 Not disclosed
Disclosure

SEC source: 0001013606-19-000167 · wf-form4_156996175134943.xml · derivative · entry 4

Lemaitre Dan · CIK 0001478479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,834

Underlying: Common Stock · 2,834 shares

Expires 2026-09-10

F5 · shares: The options vest in three equal annual installments over a three-year period commencing on September 10, 2019.

F2 · price: The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 5,000 shares of common stock granted to the reporting person on December 10, 2009, (ii) an option for 2,000 shares of common stock granted to the reporting person on May 20, 2010, and (iii) an option for 2,000 shares of common stock granted to the reporting person on May 25, 2011. In exchange, the reporting person received a new stock option, for 2,834 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.